CASI Pharmaceuticals, Inc. Ordinary Shares
Symbol: CASI (NASDAQ)
1.66
▲ (2.80%) 0.045
Company Description:
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
Key Stats
- Today's Open: $1.61
- Today's High: $1.82
- Today's Low: $1.635
- Today's Volume: 11.90K
- Yesterday Close: $1.61
- Yesterday High: $1.8899
- Yesterday Low: $1.61
- Yesterday Volume: 49.91K
- Last Min Volume: 2
- Last Min High: $1.655
- Last Min Low: $1.655
- Last Min VWAP: $1.655
Company Profile
- Name: CASI Pharmaceuticals, Inc. Ordinary Shares
- Website: https://www.casipharmaceuticals.com
- Listed Date: 1996-06-12
- Location: ,
- Market Status: Active
- CIK Number: 0001962738
- SIC Code:
- SIC description:
- Market Cap: $25.41M
- Round Lot: 100
- Outstanding Shares: 15.49M
- Asset Type: CS
RECENT FILINGS FOR CASI
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-26 | SCHEDULE 13D | View |
| 2025-09-26 | 6-K | View |
| 2025-09-02 | 6-K | View |
| 2025-08-29 | 6-K | View |
| 2025-08-27 | 6-K | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-04 | 6-K | View |
| 2025-07-23 | SCHEDULE 13G/A | View |
| 2025-07-22 | 6-K | View |
| 2025-06-20 | SCHEDULE 13D/A | View |
| 2025-05-20 | 6-K | View |
| 2025-05-20 | 6-K/A | View |
| 2025-05-16 | 6-K | View |
| 2025-05-14 | 6-K | View |
| 2025-05-12 | 6-K | View |
| 2025-05-07 | 6-K | View |
| 2025-04-09 | 6-K | View |
| 2025-04-03 | 6-K | View |
| 2025-04-03 | 6-K | View |
| 2025-04-01 | 424B5 | View |
Latest News on CASI